Karo Pharma publishes the 2020 annual report
30 mars, 2021
30 mars, 2021
Today, on 30 March 2021, Karo Pharma is publishing its annual report for 2020 on the company’s website, www.karopharma.com.
For further information, please contact:
Jon Johnsson, CFO, 073-507 88 61, jon.johnsson@karopharma.com
The Annual Report is published in Swedish and English. The Swedish version represents the original version and has been translated into English.
This information is information that Karo Pharma is obliged to make public pursuant to the Swedish Securities Market Act. The information was submitted for publication on 30March, at 15:00 CET
About Karo Pharma
Karo Pharma delivers smart choices for everyday healthcare. We own and commercialize branded, original over-the-counter products and prescription medicines. Our products are available in more than 60 countries, with Europe and the Nordic region as our core markets. Karo Pharma is headquartered in Stockholm, Sweden and listed on Nasdaq Stockholm Mid Cap.
30 mars, 2021
Today, on 30 March 2021, Karo Pharma is publishing its annual report for 2020 on the company’s website, www.karopharma.com.
For further information, please contact:
Jon Johnsson, CFO, 073-507 88 61, jon.johnsson@karopharma.com
The Annual Report is published in Swedish and English. The Swedish version represents the original version and has been translated into English.
This information is information that Karo Pharma is obliged to make public pursuant to the Swedish Securities Market Act. The information was submitted for publication on 30March, at 15:00 CET
About Karo Pharma
Karo Pharma delivers smart choices for everyday healthcare. We own and commercialize branded, original over-the-counter products and prescription medicines. Our products are available in more than 60 countries, with Europe and the Nordic region as our core markets. Karo Pharma is headquartered in Stockholm, Sweden and listed on Nasdaq Stockholm Mid Cap.
Inflation
Försvarssektorn
Rapportperioden
Analys
Placera granskar fondjättarna
Inflation
Försvarssektorn
Rapportperioden
Analys
Placera granskar fondjättarna
Igår, 15:19
RevolutionRace: Kommer storägarna sälja mer?
OMX Stockholm 30
1 DAG %
Senast
2 431,64